Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Lancet (London, England)
|
November 7, 2024
Concerns regarding Gaza mortality estimates
Ruth Oratz, Steven Roth, Joel Zivot, et al.
Journal of Oncology Practice
|
September 23, 2010
Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer
Ruth Oratz, Dev Paul, Allen L Cohn, et al.
Lancet (London, England)
|
April 12, 2024
When medical duty and advocacy are one-sided, both sides suffer
Naomi T Katz, Ruth Oratz, Yvonne Steinert, et al.
Journal of Genetic Counseling
|
March 7, 2014
Cancer risk assessment using genetic panel testing: considerations for clinical application
Susan Hiraki, Erica S Rinella, Freya Schnabel, et al.
Retinal Cases & Brief Reports
|
February 11, 2016
INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS
Carly J Seidman, Paul T Finger, Joshua S Silverman, et al.
Rambam Maimonides Medical Journal
|
December 30, 2024
Antisemitism in Medicine: An International Perspective
Michael Gordon, Jerome Teitel, Ted Rosenberg, et al.
Cancer Investigation
|
November 30, 2004
A comparison of survival rates for treatment of melanoma metastatic to the brain
Anne Stone, Jay Cooper, Karen L Koenig, et al.
Lancet (London, England)
|
April 12, 2024
Hypocrisy of moral imperatives in the Israel-Hamas war
Steven Roth, Hedy S Wald, Nicole Z Spence, et al.
Journal of Oncology Practice
|
July 7, 2011
Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer
Ruth Oratz, Benjamin Kim, Calvin Chao, et al.
American Journal of Clinical Oncology
|
December 19, 2019
Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer
Heather T Gold, Huibo Shao, Ruth Oratz, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Lancet (London, England)
|
November 7, 2024
Concerns regarding Gaza mortality estimates
Ruth Oratz, Steven Roth, Joel Zivot, et al.
Journal of Oncology Practice
|
September 23, 2010
Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer
Ruth Oratz, Dev Paul, Allen L Cohn, et al.
Lancet (London, England)
|
April 12, 2024
When medical duty and advocacy are one-sided, both sides suffer
Naomi T Katz, Ruth Oratz, Yvonne Steinert, et al.
Journal of Genetic Counseling
|
March 7, 2014
Cancer risk assessment using genetic panel testing: considerations for clinical application
Susan Hiraki, Erica S Rinella, Freya Schnabel, et al.
Retinal Cases & Brief Reports
|
February 11, 2016
INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS
Carly J Seidman, Paul T Finger, Joshua S Silverman, et al.
Rambam Maimonides Medical Journal
|
December 30, 2024
Antisemitism in Medicine: An International Perspective
Michael Gordon, Jerome Teitel, Ted Rosenberg, et al.
Cancer Investigation
|
November 30, 2004
A comparison of survival rates for treatment of melanoma metastatic to the brain
Anne Stone, Jay Cooper, Karen L Koenig, et al.
Lancet (London, England)
|
April 12, 2024
Hypocrisy of moral imperatives in the Israel-Hamas war
Steven Roth, Hedy S Wald, Nicole Z Spence, et al.
Journal of Oncology Practice
|
July 7, 2011
Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer
Ruth Oratz, Benjamin Kim, Calvin Chao, et al.
American Journal of Clinical Oncology
|
December 19, 2019
Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer
Heather T Gold, Huibo Shao, Ruth Oratz, et al.
Page
of 3